| Scientific Name | Pharmaceutical form | Strength Value |
|---|---|---|
Inactivated Newcastle Disease virus Ulster 2C strain/ Inactivated Infectious Bronchitis virus Mass 41 strain/ Inactivated Infectious Bursal Disease virus VNJO strain |
Emulsion for injection |
NLT 50- , NLT 80- , NLT 5- |
Inactivated Newcastle Disease virus Ulster 2C strain |
Emulsion for injection |
NLT 50- |
Live attenuated fowl pox virus DCEP25 strain |
Lyophilisate and solvent for suspension for injection |
NLT 3.0- |
Attenuated Infectious Bronchitis Coronavirus strain CR88121 |
Effervescent tablet |
NLT 4.0- |
Avian Encephalomyelitis Virus/ Fowl Pox Virus |
Lyophilisate and solvent for suspension for injection |
NLT 10ˆ2.7- , NLT 10ˆ2.2- |
Inactivated Mycoplasma agalactiae N84 strain/Inactivated Mycoplasma capricolum strain 27343/ Inactivated Mycoplasma mycoides subsp mycoides HH strain |
Suspension for injection |
1:20U , 1:20U , 1:20U |
Attenuated feline rhinotracheitis herpesvirus- FHV F2 strain/ Inactivated feline Calicivirosis antigens- FCV 431 and G1 strains/ Attenuated feline panleucopenia virus- PLI IV |
Lyophilisate and solvent for suspension for injection |
NLT 10ˆ4.9- , NLT 2.0- , NLT 10ˆ3.5- |
Inactivated Avian influenza virus H9N2 AG415 |
Emulsion for injection |
7log10 PFU/dose |
Live Newcastle Disease Virus clone CL 79 |
Lyophilisate for suspension |
10^6.5EID50 |
Inactivated subunit H5 Hemagglutinin (HA) of High pathogenic Avian Influenza (HPAI) virus H5N1/ Inactivated Newcastle Disease |
Emulsion for injection |
NLT 256- , NLT 128- |